Sv7 Impact Medicine Fund LP
3 additional principals, 2 additional placement agents
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- +195%reported GAV
Reported gross assets rose from $101M to $297M between the Form ADV filings of 28 Mar 2024 and 24 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Amounts, each with its basis
- Vintage
- unknownno dated first sale or first report yet
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $250Mwhat may be sold, not what was raised; file 021-342712, 021-249408, sworn by the adviser or filed under this vehicle
- Form D sold
- $0as of the filing of Jun 25, 2019
- First sale
- unknown
- Reported GAV
- $297Mon the Form ADV filed Mar 24, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 38
- Reported on ADV
- Mar 28, 2019 to Mar 24, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Lifecycle
Unknown
Lifecycle
The fund's own reporting through time
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 28, 2019 | Venture Capital Fund | $0 | 0 | 0% | yes | ||
| Jul 8, 2019 | Venture Capital Fund | $123,125 | 16 | $5.0M | 0% | yes | |
| Mar 17, 2020 | Venture Capital Fund | $247M | 34 | $5.0M | 0% | yes | |
| Mar 17, 2021 | Venture Capital Fund | $40.8M | 34 | $5.0M | 0% | yes | |
| Mar 31, 2022 | Venture Capital Fund | $104M | 38 | $5.0M | 2% | yes | |
| Mar 30, 2023 | Venture Capital Fund | $97.3M | 38 | $5.0M | 2% | yes | |
| Mar 28, 2024 | Venture Capital Fund | $101M | 38 | $5.0M | 2% | yes | |
| Mar 24, 2026 | Venture Capital Fund | $297M | 38 | $5.0M | 2% |
Principals and agents
- Michael Ross Executive Officer
- James Costine Executive Officer
- Catherine Bingham Executive Officer
Service providers
- AuditorRSM · LONDON, United KingdomForm ADV filed Mar 24, 2026 reports.adviserinfo.sec.gov
- AdministratorAztec · FAREHAM, United KingdomForm ADV filed Mar 24, 2026 reports.adviserinfo.sec.gov
- CustodianBARCLAYS BANK PLC · LONDON, United KingdomForm ADV filed Mar 24, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.Investments attributed to this vehicle
Timeline
- Mar 30, 2023Auditor changed: RSM replaced PwC, first reported on the Form ADV filed March 30, 2023 (previous filing March 31, 2022)Auditor changed Fact Form ADV
- Jun 25, 2019SV7 Impact Medicine Fund LP filed Form D: no sales yet of $250,000,000, Venture Capital FundForm D filed Fact Form D
- Mar 28, 2019Sv7 Impact Medicine Fund LP first reported on Form ADV by SV Health Managers LLP (Venture Capital Fund)Fund first reported on Form ADV Fact Form ADV
Evidence
Every observation on this vehicle
- Entity type: Limited Partnership Jun 25, 2019 Fact Form D
- Form D fund type: Venture Capital Fund Jun 25, 2019 Fact Form D
- Form D industry group: Pooled Investment Fund Jun 25, 2019 Fact Form D
- Amendment: false Jun 25, 2019 Fact Form D
- Revenue range (Form D): Decline to Disclose Jun 25, 2019 Fact Form D
- Incorporated: withinFiveYears Jun 25, 2019 Fact Form D
- Jurisdiction: UNITED KINGDOM Jun 25, 2019 Fact Form D
- Amount sold (Form D): $0 Jun 25, 2019 Fact Form D
- Offering amount (Form D): $250M Jun 25, 2019 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Jun 25, 2019 Fact Form D
- Investors (Form D): 0 Jun 25, 2019 Fact Form D
- Minimum investment (Form D): 0 Jun 25, 2019 Fact Form D
- Securities offered: Equity, pooled Jun 25, 2019 Fact Form D
- Office address: Jun 25, 2019 Fact Form D
- Year of incorporation: 2019 Jun 25, 2019 Fact Form D
Relationships across DFX
on 1 other DFX graph
Sv7 Impact Medicine Fund LP is the same institution as 1 record in RIA and Wealth.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
- Form D filed2019-06-25source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.